Katholisches Klinikum Mainz

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Atrial fibrillation1 trial
• Coronary artery disease1 trial
• Familial hypercholesterolaemia1 trial
• Heart failure1 trial
• High blood pressure1 trial
• Metastatic breast cancer1 trial
• Stroke1 trial

Phase

• Phase 32 trials
• Phase 41 trial

Status

• Completed3 trials
• Active, not recruiting2 trials

Lead sponsor

• Boehringer Ingelheim1 trial
• Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company1 trial
• Pfizer1 trial
• Population Health Research Institute1 trial
• ReCor Medical, Inc.1 trial

Running trials

• Active, not recruiting

  Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia

  NCT04579367· Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company· Source

• Active, not recruiting

  A Study of the ReCor Medical Paradise System in Clinical Hypertension

  NCT02649426· ReCor Medical, Inc.· Source

Closed trials

• Completed

  EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)

  NCT04509674· Phase 3· Boehringer Ingelheim· Source

• Completed

  Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation

  NCT01938248· Phase 4· Population Health Research Institute· Source

• Completed

  A Study of Palbociclib (PD-0332991) + Letrozole vs. Letrozole For 1st Line Treatment Of Postmenopausal Women With ER+/HER2- Advanced Breast Cancer (PALOMA-2)

  NCT01740427· Phase 3· Pfizer· Source